Clinical Research, Pharma & Healthcare FinancingResponse Pharma Completes Phase 2 Enrollment for RDX-002Business WireFebruary 7, 2025February 12, 2025 by Business WireFebruary 7, 2025February 12, 2025021 Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a...